ITHACA — Rheonix, Inc., an Ithaca–based microfluidics company, today announced the addition of Frank Gill as vice president of manufacturing.
Gill will be responsible for formulating and executing the company’s operations strategy as it scales from prototype volumes to fully-automated production of life science and in-vitro diagnostics products, the company said in a news release.
Gill will oversee manufacturing of Rheonix-instrument platforms, reagent kits, and the Rheonix CARD system, an automated-microfluidic platform capable of analyzing raw samples in a variety of applications, the company said.
(Sponsored)
“Borderline” Overtime Exemptions Require Careful Analysis and Precautionary Measures
Q: We have an employee who we believe is properly classified as exempt from receiving overtime under the Fair Labor Standards Act (FLSA) but it is a “borderline” case. In
How to Generate Staff Buy-In for Cloud Document Management
How businesses manage important documents has changed quite a bit throughout history. Information that used to be housed in filing cabinets and rolodexes is now stored digitally, often in one
Most recently, Gill served as director of reagent-manufacturing operations at 454 Life Sciences, a division of the Switzerland–based Roche Group.
Contact Reinhardt at ereinhardt@cnybj.com
